Stroke Mismatch Volume with the Use of ABC/2 Is Equivalent to Planimetric Stroke Mismatch Volume

REFERENCES

1. 1.↵
   1. Kothari RU,
   2. Brott T,
   3. Broderick JP,
   4. et al

   . The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996;27:1304–05

   Abstract/FREE Full Text
2. 2.↵
   1. Gebel JM,
   2. Sila CA,
   3. Sloan MA,
   4. et al

   . Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trial. Stroke 1998;29:1799–801

   Abstract/FREE Full Text
3. 3.↵
   1. Huttner HB,
   2. Steiner T,
   3. Hartmann M,
   4. et al

   . Comparison of ABC/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhage. Stroke 2006;37:404–08

   Abstract/FREE Full Text
4. 4.↵
   1. Straka M,
   2. Albers GW,
   3. Bammer R

   . Real time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging 2010;32:1024–37

   CrossRefPubMed
5. 5.↵
   1. Luby M,
   2. Ku KD,
   3. Latour LL,
   4. et al

   . Visual perfusion-diffusion mismatch is equivalent to quantitative mismatch. Stroke 2011;42:1010–14

   Abstract/FREE Full Text
6. 6.↵
   1. Schellinger PD,
   2. Jansen O,
   3. Fiebach JB,
   4. et al

   . Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. AJNR Am J Neuroradiol 2000;21:1184–89

   Abstract/FREE Full Text
7. 7.↵
   1. Hacke W,
   2. Albers G,
   3. Al-Rawi Y,
   4. et al.

   , DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73

   Abstract/FREE Full Text
8. 8.↵
   1. Furlan AJ,
   2. Eyding D,
   3. Albers GW,
   4. et al

   . Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006;37:1227–31

   Abstract/FREE Full Text
9. 9.↵
   1. Hacke W,
   2. Furlan AJ,
   3. Al-Rawi Y,
   4. et al

   . Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141–50

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Davis SM,
    2. Donnan GA,
    3. Parsons MW,
    4. et al.

    , EPITHET Investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299–309

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Butcher KS,
    2. Parsons M,
    3. MacGregor L,
    4. et al.

    , EPITHET Investigators. Refining the perfusion-diffusion mismatch hypothesis. Stroke 2005;36:1153–59

    Abstract/FREE Full Text
12. 12.↵
    1. Albers GW,
    2. Thijs VN,
    3. Wechsler L,
    4. et al.

    , DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006;60:508–17

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Sims JR,
    2. Gharai LR,
    3. Schaefer PW,
    4. et al

    . ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 2009;72:2104–10

    CrossRef
14. 14.↵
    1. Pedraza S,
    2. Puig J,
    3. Blasco G,
    4. et al

    . Reliability of the ABC/2 method in determining acute infarct volume. J Neuroimaging 2012;22:155–59

    CrossRefPubMed
15. 15.↵
    1. Vogt G,
    2. Laage R,
    3. Shuaib A,
    4. et al.

    , VISTA Collaboration. Initial lesion volume is an independent predictor of clinical stroke outcome at day 90: an analysis of the Virtual International Stroke Trials Archive (VISTA) database. Stroke 2012;43:1266–72

    Abstract/FREE Full Text
16. 16.↵
    1. Warach S,
    2. Al-Rawi Y,
    3. Furlan AJ,
    4. et al

    . Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials. Stroke 2012;43:2313–18

    Abstract/FREE Full Text
17. 17.↵
    1. Luby M,
    2. Bykowski JL,
    3. Schellinger PD,
    4. et al

    . Intra- and interrater reliability of ischemic lesion volume measurements on diffusion-weighted, mean transit time and fluid-attenuated inversion recovery MRI. Stroke 2006;37:2951–56

    Abstract/FREE Full Text
18. 18.↵
    1. Gómez-Mariño R,
    2. André C,
    3. Novis SA

    . Volumetric determination of cerebral infarction in the acute phase using skull computed tomography without contrast: comparative study of 3 methods. Arq Neuropsiquiatr 2001;59:380–83

    PubMed